374 studies found for:    alzheimer | Open Studies | Interventional Studies
Show Display Options
Rank Status Study
21 Recruiting Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild Dementia Due to Alzheimer's Disease
Conditions: Alzheimer Disease;   Dementia, Alzheimer Type
Interventions: Drug: E2609;   Drug: Placebo
22 Recruiting A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Nilvadipine;   Drug: Placebo
23 Recruiting Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Procedure: Paired Associative Stimulation;   Procedure: Paired Associative Stimulation-Control
24 Recruiting An Efficacy and Safety Study of AZD3293 in Early Alzheimer's Disease
Condition: Alzheimer´s Disease
Interventions: Drug: AZD3293;   Drug: Placebo
25 Recruiting Alzheimer's Disease Multiple Intervention Trial
Condition: Alzheimer's Disease
Interventions: Behavioral: Home based occupational therapy;   Behavioral: Best practices primary care
26 Unknown  Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
Condition: Alzheimer's Dementia
Intervention: Device: Resonator
27 Recruiting Study to Evaluate Coconut Oil for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Coconut Oil Beverage;   Other: Placebo Beverage
28 Not yet recruiting The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Device: Deep Brain Stimulation (Beijing PINS Medical Co., Ltd)
29 Recruiting Retinal Neurodegenerative Signs in Alzheimer's Diseases
Condition: Alzheimer's Disease
Intervention: Other: Ophthalmological examination & Questionnaire
30 Unknown  Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Octohydroaminoacridine Succinate Tablets;   Drug: Octohydroaminoacridine succinate Tablets;   Drug: Placebo
31 Recruiting Multi-modal Neuroimaging in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Behavioral: Memory assessment;   Biological: Circulating biomarkers measure;   Genetic: ApoE4;   Other: Brain imaging examination MRI and PET examinations
32 Recruiting Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Prazosin;   Drug: Placebo
33 Unknown  Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Dietary Supplement: Curcumin Formulation;   Dietary Supplement: Placebo
34 Recruiting Safety Study of MT-4666 in Subjects With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: MT-4666
35 Recruiting Sleep, Aging and Risk for Alzheimer's Disease
Conditions: Sleep Disordered Breathing;   Alzheimer's Disease
Intervention: Device: Continuous positive airway pressure (CPAP)
36 Recruiting 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine
37 Recruiting Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study.
Condition: Alzheimer Disease
Interventions: Other: High intensity aerobic exercise+strength;   Other: Low intensity aerobic exercise+strength
38 Recruiting Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: EVP-6124;   Drug: Placebo
39 Recruiting Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: EVP-6124;   Drug: Placebo
40 Recruiting A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: AZD0530 100mg daily;   Drug: AZD0530 125mg daily;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years